Flavonoid Compounds in the Prevention and Treatment of Prostate Cancer

  • Graham E. Kelly
  • Alan J. Husband
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 81)


Compounds based on a flavonoid (di-phenolic) ring structure are emerging as a potentially important new class of pharmaceutical compounds with a broad range of biological activities, most prominent of which is their potential role as anticancer agents.


  1. 1.
    Adlercreutz, H., Fotsis, T., Heikkinen, R., Dwyer, J. T., Woods, M., Goldin, B. R., and Gorbach, S. L. (1982) Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancerai. Lancet 2, 1295–1299.PubMedCrossRefGoogle Scholar
  2. 2.
    Ekman, P. (1989) BPH epidemiology and risk factors. Prostate Suppl. 2, 23–31.PubMedCrossRefGoogle Scholar
  3. 3.
    Dhom, G. (1991) Epidemiology of hormone-depending tumors, in Endocrine Dependent Tumors (Voigt, K. D. and Knabbe, C., eds.), Raven Press, New York, pp. 1–42.Google Scholar
  4. 4.
    Mills, P. K., Beeson, W. L., Phillips, R. L., and Fraser, G. E. (1989) Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 64, 598–604.PubMedCrossRefGoogle Scholar
  5. 5.
    Dunn, J. E. (1975) Cancer epidemiology in populations of the United States—with emphasis on Hawaii and California—and Japan. Cancer Res. 35, 3240–3245.PubMedGoogle Scholar
  6. 6.
    Kolonel, L. N., Hankin, J. H., and Nomura, A. M. Y. (1986) Multiethnic studies of diet, nutrition and cancer in Hawaii, in Nutrition And Cancer (Hayashi, Y., ed.), Japanese Science Society Press, Tokyo, pp. 29–40.Google Scholar
  7. 7.
    Setchell, K. D. R. and Adlercreutz, H. (1988) Mammalian lignans and phytooestrogens. Recent studies on their formation, metabolism and biological role in health and disease, in Role of the Gut Flora in Toxicity and Cancer (Rowland, I. R., ed.), Academic Press Ltd, San Diego, pp. 315–345.Google Scholar
  8. 8.
    Kelly, G. E., Nelson, C., Waring, M. A., Joannou, G. E., and Reeder, A.Y. (1993) Metabolites of dietary (soya) isoflavones in human urine. Clin. Chim. Acta 223, 9–22.PubMedCrossRefGoogle Scholar
  9. 9.
    Morton, M. S., Chan, P. S., Cheng, C., Blacklock, N., Matos-Ferreira, A., Abranches-Monteiro L., et al. (1997) Lignans and isoflavonoids in plasma and prostatic fluid in men: Samples from Portugal, Hong Kong, and the United Kingdom. Prostate 32, 122–128.PubMedCrossRefGoogle Scholar
  10. 10.
    Miksicek, R. J. (1994) Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49, 153–160.PubMedCrossRefGoogle Scholar
  11. 11.
    Collins, B. M., McLachlan, J. A., and Arnold, S. F. (1997) The estrogenic and antiestrogenic activities of phytochemicals with human estrogen receptor expressed in yeast. Steroids 62, 365–372.PubMedCrossRefGoogle Scholar
  12. 12.
    Miksicek, R. J. (1993) Commonly occurring plant flavonoids have estrogenic activity. Mol. Pharmacol. 44, 37–43.PubMedGoogle Scholar
  13. 13.
    Cato, A. C., Miksicek, R., Schutz, G., Arnemann, J., and Beato, M. (1086) The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction. EMBO J. 5, 2237–2240.Google Scholar
  14. 14.
    Campbell, D. R. and Kurzer, M. S. (1993) Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J. Steroid Biochem. Mol. Biol. 46, 381–388.PubMedCrossRefGoogle Scholar
  15. 15.
    Morton, M. S., Griffiths, K., and Blacklock, N. (1996) The preventive role of diet in prostatic disease. Br. J. Urol. 77, 481–493.PubMedCrossRefGoogle Scholar
  16. 16.
    Evans, B. A., Griffiths, K., and Morton, M. S. (1995) Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J. Endocrinol. 147, 295–302.PubMedCrossRefGoogle Scholar
  17. 17.
    Bruchovsky, N. and Wilson, J. D. (1968) The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro. J. Biol. Chem. 243, 2012–2021.PubMedGoogle Scholar
  18. 18.
    Anderson, K. M. and Liao, S. (1968) Selective retention of dihydrotestosterone by prostatic nuclei. Nature 219, 277–279.PubMedCrossRefGoogle Scholar
  19. 19.
    Ross, R. K., Bernstein, L., Lobo, R. A., Shimizu, H., Stanczyk, F. Z., Pike, M. C., and Henderson, B. E. (1992) 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339, 887–889.PubMedCrossRefGoogle Scholar
  20. 20.
    Keung, W. M. (1995) Dietary estrogenic isoflavones are potent inhibitors of beta-hydroxysteroid dehydrogenase of P. testosteronii. Biochem. Biophys. Res. Commun. 215, 1137–1144.PubMedCrossRefGoogle Scholar
  21. 21.
    Wong, C. K. and Keung, W. M. (1997) Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase (EC Biochem. Biophys. Res. Commun. 233, 579–583.PubMedCrossRefGoogle Scholar
  22. 22.
    Sun, X.Y., Plouzek, C. A., Henry, J. P., Wang, T. T., and Phang, J. M. (1998) Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells. Cancer Res. 58, 2379–2384.PubMedGoogle Scholar
  23. 23.
    Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., et al. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262, 5592–5595.PubMedGoogle Scholar
  24. 24.
    Suolinna, E. M., Lang, D. R., and Racker, E. (1974) Quercetin, an artificial regulator of the high aerobic glycolysis of tumor cells. J. Natl. Cancer Inst. 53, 1515–1519.PubMedGoogle Scholar
  25. 25.
    Shoshan, V. and MacLennan, D. H. (1981) Quercetin interaction with the (Ca2++ Mg2+)-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 256, 887–892.PubMedGoogle Scholar
  26. 26.
    Ono, K., Nakane, H., Fukushima, M., Chermann, J. C., and Barre-Sinoussi, F. (1990) Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur. J. Biochem. 190, 469–476.PubMedCrossRefGoogle Scholar
  27. 27.
    Glossmann, H., Presek, P., and Eigenbrodt, E. (1981) Quercetin inhibits tyrosine phosphorylation by the cyclic nucleotide-independent, transforming protein kinase, pp60src. Naunyn Schmiedebergs Arch. Pharmacol. 317, 100–102.PubMedCrossRefGoogle Scholar
  28. 28.
    Matter, W. F., Brown, R. F., and Vlahos, C. J. (1992) The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem. Biophys. Res. Commun. 186, 624–631.PubMedCrossRefGoogle Scholar
  29. 29.
    Prajda, N., Singhal, R. L., Yeh, Y. A., Olah, E., Look, K. Y., and Weber, G. (1995) Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetin. Life Sci. 56, 1587–1593.PubMedCrossRefGoogle Scholar
  30. 30.
    Rizzo, M. T. and Weber, G. (1994) 1-Phosphatidylinositol 4-kinase: an enzyme linked with proliferation and malignancy. Cancer Res. 54, 2611–2614.PubMedGoogle Scholar
  31. 31.
    Yoshida, M., Yamamoto, M., and Nikaido, T. (1992) Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res. 52, 6676–6681.PubMedGoogle Scholar
  32. 32.
    Scambia, G., Ranelletti, F. O., Panici, P. B., Piantelli, M., Bonanno, G., De Vincenzo, R., et al. (1990) Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. Br. J. Cancer 62, 942–946.PubMedCrossRefGoogle Scholar
  33. 33.
    Wei, Y. Q., Zhao, X., Kariya, Y., Fukata, H., Teshigawara, K., and Uchida, A. (1994) Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res. 54, 4952–4957.PubMedGoogle Scholar
  34. 34.
    Avila, M. A., Velasco, J. A., Cansado, J., and Notario, V. (1994) Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res. 54, 2424–2428.PubMedGoogle Scholar
  35. 35.
    Constantinou, A. and Huberman, E. (1995) Genistein as an inducer of tumor cell differentiation: Possible mechanisms of action. Proc. Soc. Exp. Biol. Med. 208, 109–115.PubMedGoogle Scholar
  36. 36.
    Traganos, F., Ardelt, B., Halko, N., Bruno, S., and Darzynkiewicz, Z. (1992) Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res. 52, 6200–6208.PubMedGoogle Scholar
  37. 37.
    Constantinou, A., Kiguchi, K., and Huberman, E. (1990) Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res. 50, 2618–2624.PubMedGoogle Scholar
  38. 38.
    Peterson, G. and Barnes, S. (1991) Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance gene. Biochem. Biophys. Res. Commun. 179, 661–667.PubMedCrossRefGoogle Scholar
  39. 39.
    Peterson, G. and Barnes, S. (1996) Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ. 7, 1345–1351.PubMedGoogle Scholar
  40. 40.
    Monti, E. and Sinha, B. K. (1994) Antiproliferative effect of genistein and adriamycin against estrogen-dependent and-independent human breast carcinoma cell lines. Anticancer Res. 14, 1221–1226.PubMedGoogle Scholar
  41. 41.
    Pagliacci, M. C., Smacchia, M., Migliorati, G., Grignani, F., Riccardi, C., and Nicoletti, I. (1994) Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur. J. Cancer 30A, 1675–1682.PubMedCrossRefGoogle Scholar
  42. 42.
    Matsukawa, Y., Marui, N., Sakai, T., Satomi, Y., Yoshida, M., Matsumoto, K., et al. (1993) Genistein arrests cell cycle progression at G2-M. Cancer Res. 53, 1328–1331.PubMedGoogle Scholar
  43. 43.
    Yanagihara, K., Ito, A., Toge, T., and Numoto, M. (1993) Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 53, 5815–5821.PubMedGoogle Scholar
  44. 44.
    Peterson, G. and Barnes, S. (1993) Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 22, 335–345.PubMedCrossRefGoogle Scholar
  45. 45.
    Schweigerer, L., Christeleit, K., Fleischmann, G., Adlercreutz, H., Wahala, K., Hase, T., et al. (1992) Identification in human urine of a natural growth inhibitor for cells derived from solid paediatric tumours. Eur. J. Clin. Invest. 22, 260–264.PubMedCrossRefGoogle Scholar
  46. 46.
    Akiyama, T. and Ogawara, H. (1991) Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol. 201, 362–370.PubMedCrossRefGoogle Scholar
  47. 47.
    Constantinou, A., Mehta, R., Runyan, C., Rao, K., Vaughan, A., and Moon, R. (1995) Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. J. Natural Products 58, 217–225.CrossRefGoogle Scholar
  48. 48.
    Watanabe, T., Kondo, K., and Oishi, M. (1991) Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases. Cancer Res. 51, 764–768.PubMedGoogle Scholar
  49. 49.
    Uckun, F. M., Evans, W. E., Forsyth, C. J., Waddick, K. G., Ahlgren, L. T., Chelstrom, L. M., et al. (1995) Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 267, 886–891.PubMedCrossRefGoogle Scholar
  50. 50.
    Fotsis, T., Pepper, M., Adlercreutz, H., Hase, T., Montesano, R., and Schweigerer, L. (1995) Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J. Nutr. 125(3 Suppl), 790S–797S.PubMedGoogle Scholar
  51. 51.
    Bergan, R., Kyle, E., Nguyen, P., Trepel, J., Ingui, C., and Neckers, L. (1996) Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-1-integrin. Clin. Exp. Metastasis 14, 389–398.PubMedCrossRefGoogle Scholar
  52. 52.
    Carlson, B. A., Dubay, M. M., Sausville, E. A., Brizuela, L., and Worland, P. J. (1996) Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Cancer Res. 56, 2973–2978.PubMedGoogle Scholar
  53. 53.
    Shapiro, G. I., Koestner, D. A., Matranga, C. B., and Rollins, B. J. (1999) Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines. Clin. Cancer Res. 5, 2925–2938.PubMedGoogle Scholar
  54. 54.
    Drees, M., Dengler, W. A., Roth, T., Labonte, H., Mayo, J., Malspeis, L., et al. (1997) Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells. Clin. Cancer Res. 3, 273–279.PubMedGoogle Scholar
  55. 55.
    Axelson, M., Kirk, D. N., Farrant, R. D., Cooley, G., Lawson, A. M., and Setchell, K. D. (1982) The identification of the weak oestrogen equol [7-hydroxy-3-(4′-hydroxyphenyl)chroman] in human urine. Biochem. J. 201, 353–357.PubMedGoogle Scholar
  56. 56.
    Bannwart, C., Adlercreutz, H., Wahala, K., Kotiaho, T., Hesso, A., Brunow, G., and Hase, T. (1988) Identification of the phyto-oestrogen 3′,7-dihydroxyisoflavan, an isomer of equol, in human urine and cow’s milk. Biomed. Environ. Mass Spectrom. 17, 1–6.PubMedCrossRefGoogle Scholar
  57. 57.
    Joannou, G. E., Kelly, G. E., Reeder, A. Y., Waring, M., and Nelson, C. (1995) A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J. Steroid Biochem. Mol. Biol. 54, 167–184.PubMedCrossRefGoogle Scholar
  58. 58.
    Bannwart, C., Fotsis, T., Heikkinen, R., and Adlercreutz, H. (1984) Identification of the isoflavonic phytoestrogen daidzein in human urine. Clin. Chim. Acta 136, 165–172.PubMedCrossRefGoogle Scholar
  59. 59.
    Kok, J. W., Veldman, R. J., Klappe, K., Koning, H., Filipeanu, C. M., and Muller, M. (2000) Differential expression of sphingolipids in MRP1 overexpressing HT29 cells. Int. J. Cancer 87, 172–178.PubMedCrossRefGoogle Scholar
  60. 60.
    Makela, S., Davis, V. L., Tally, W. C., Korkman, J., Salo, L., Vihko, R., et al. (1994) Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ. Health Perspect. 102, 572–578.PubMedCrossRefGoogle Scholar
  61. 61.
    Wang, C. and Kurzer, M. S. (1997) Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr. Cancer 28, 236–247.PubMedCrossRefGoogle Scholar
  62. 62.
    Setchell, K. D., Borriello, S. P., Hulme, P., Kirk, D. N., and Axelson, M. (1984) Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am. J. Clin. Nutr. 40, 569–578.PubMedGoogle Scholar
  63. 63.
    Ingram, D., Sander, K., Kolybaba, M., and Lopez, D. (1998) Case-control study of phyto-oestrogens and breast cancer. Lancet 350, 990–994.CrossRefGoogle Scholar
  64. 64.
    Adlercreutz, H., Goldin, B. R., Gorbach, S. L., Hockerstedt, K. A., Watanabe, S., Hamalainen, E. K., et al. (1995) Soybean phytoestrogen intake and cancer risk. J. Nutr. 125(3 Suppl), 757S–770S.PubMedGoogle Scholar
  65. 65.
    Martin, P. M., Horwitz, K. B., Ryan, D. S., and McGuire, W. L. (1978) Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103, 1860–1867.PubMedCrossRefGoogle Scholar
  66. 66.
    Zhou, H., Goldman, M., Wu, J., Woestenborghs, R., Hassell, A.E., Lee, P., et al. (1998) A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection. J. Clin. Pharmacol. 38, 593–602.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2003

Authors and Affiliations

  • Graham E. Kelly
    • 1
  • Alan J. Husband
    • 1
  1. 1.Novogen LimitedNorth RydeAustralia

Personalised recommendations